Filter by: patients
Home > Community Treatment Reports and Side Effects > Rasagiline Treatment Report
What is Rasagiline?

Rasagiline is an anti-Parkinson's agent and MAO inhibitor which can enhance the activity of dopamine. It is used for initial monotherapy or as adjunct to levodopa in the treatment of idiopathic Parkinson's disease.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Parkinson's Disease 777 253 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Stiffness/Spasticity 32 15 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Other 30 13 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Increase effect of another treatment 24 15 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Balance problems 5 2 Efficacy_moderate Efficacy_slight
Improve mobility 5 0

See all 801 patients currently taking Rasagiline

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 20
Moderate
 30
Mild
 49
None
 191

Commonly reported side effects, conditions, and hospitalizations associated with Rasagiline

Urinary frequency 21
Headaches 15
Anxious mood 12
Difficulty falling asleep 10
Nausea 9
Nasal congestion 6
See all 89 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Rasagiline. See all 14 dosages ►

  daily 0.05 mg daily 1 mg every other week 1 mg weekly 0.5 mg daily 1 mg daily 1.5 mg daily 2 mg daily 5 mg daily 8 mg daily
  19 Number of Patients: 19 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 138 Number of Patients: 138 633 Number of Patients: 633 3 Number of Patients: 3 10 Number of Patients: 10 4 Number of Patients: 4 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Rasagiline (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 72   Did not seem to work: 38%
Side effects too severe 67   Side effects too severe: 36%
Doctor's advice 55   Doctor's advice: 29%
Other 23   Other: 12%
Expense 19   Expense: 10%
Personal research 11   Personal research: 6%
Not indicated 4   Not indicated: 2%
Course of treatment ended 3   Course of treatment ended: 2%
Change in health plan coverage 2   Change in health plan coverage: 1%

See all 179 patients who’ve stopped taking Rasagiline

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Rasagiline

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Rasagiline

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Rasagiline

Always
 245 84%
Usually
 25 9%
Sometimes
 3 1%
Never
 17 6%

Burden

Difficulty being on treatment

Burden of Rasagiline

Very
 11 4%
Somewhat
 20 7%
A little
 31 11%
Not at all
 228 79%

Cost

Paid out of pocket

Cost of Rasagiline

$200+
 20 10%
$100-199
 19 9%
$50-99
 34 16%
$25-49
 54 26%
< $25
 82 39%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 27, 2012.